Correlation of Tacrolimus Levels and Metabolizer Status Based on CYP3A5 Polymorphism in Indian Lung Transplant Recipients

被引：0
|
作者：
Jindal, A. [1 ]
Rahulan, V. [1 ]
Sagadevan, S. [1 ]
Dutta, P. [1 ]
Attawar, S. [1 ]
机构：
[1] Gleneagles Global Hlth City, Inst Heart & Lung Transplant, Pulm Crit Care & Sleep Med, Chennai, Tamil Nadu, India
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.1045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1035
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 50 条
  • [41] The influence of genetic CYP3A5 polymorphism on tacrolimus serum concentration in liver transplant patients
    Albsoul-Younes, Abla
    Al-Jabra, Rabia
    Yousef, Almotessem
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1345 - 1345
  • [42] Influence of Cyp3A4, Cyp3A5 and ABCB1 Polymorphisms on Tacrolimus Concentrations and Rejection Risk in Indian Kidney Transplant Recipients
    Mukkavilli, Kamal Kiran
    Khan, Mohammed Shoeb A.
    Donakonda, Arun Kumar
    Gangisetty, Suma Rama Gopal
    Poojaveli, Dileena
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (01) : 42 - 45
  • [43] Impact of CYP3A5 genotype and cystic fibrosis on extended-release tacrolimus (LCPT) exposure in lung transplant recipients
    Elmasri, Annesti F.
    Park, Jeong M.
    Fitzgerald, Linda
    McMurry, Katie
    Patil, Snehal
    Fritsche, Lars G.
    Pasternak, Amy L.
    PHARMACOGENETICS AND GENOMICS, 2023, 33 (08): : 199 - 200
  • [44] Tailored Immunosuppression Using CYP3A5 Metaboliser Status in Heart and Lung Transplant Cases - An Indian Study
    Ratnagiri, R.
    Rahulan, V.
    Jindal, A.
    Attawar, S.
    Dutta, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S504 - S504
  • [45] Effect of the CYP3A5 6986A>G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis
    Buendia, J. A.
    Bramuglia, G.
    Staatz, C. E.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 657 - 657
  • [46] Single Nucleotide Polymorphism of CYP3A5 Influences the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial
    Billing, H.
    Hoecker, B.
    Fichtner, A.
    van Damme-Lombaerts, R.
    Friman, S.
    Jaray, J.
    Vondrak, K.
    Sarvary, E.
    Dello Strologo, L.
    Armstrong, V.
    Oellerich, M.
    Toenshoff, B.
    von Ahsen, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 147 - 147
  • [47] Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
    Zong, Huiying
    Zhang, Yundi
    Liu, Fengxi
    Zhang, Xiaoming
    Yang, Yilei
    Cao, Xiaohong
    Li, Yue
    Li, Anan
    Zhou, Penglin
    Gao, Rui
    Li, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] Single Nucleotide Polymorphism Of Cyp3a5 Influences The Exposure To Tacrolimus In Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy Of The Twist Trial
    Heiko, Billing
    Britta, HOecker
    Alexander, Fichtner
    Rita, Van Dammelombaerts
    Friman, Styrbjorn
    Jenoe, Jaray
    Karel, Vondrak
    Luca, Dello Strologo
    Eniko, Sarvary
    Victor, Armstrong
    Michael, Oellerich
    Nicolas, Von Ahsen
    Burkhard, Toenshoff
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1693 - 1694
  • [49] Single Nucleotide Polymorphism of CYP3A5 Influences the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial
    Billing, H.
    Hoecker, B.
    Fichtner, A.
    van Damme-Lombaerts, R.
    Friman, S.
    Jaray, J.
    Vondrak, K.
    Sarvary, E.
    Dello Strologo, L.
    Armstrong, V.
    Oellerich, M.
    Toenshoff, B.
    von Ahsen, N.
    TRANSPLANTATION, 2014, 98 : 147 - 147
  • [50] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331
12345